Mass transfer limitations to the performance of membrane bioartificial liver support devices

International Journal of Artificial Organs

Volumn 19, Issue 1, 1996, Pages 18-35

  Catapano, G ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Bioartificial; Hepatocytes; Liver; Mass transfer; Membrane; Support

Indexed keywords

ARTIFICIAL ORGANS; MEMBRANES; TRANSPORT PROPERTIES;

BIOARTIFICIAL; BIOARTIFICIAL DEVICES; BIOARTIFICIAL LIVER; HEPATOCYTES; MASS TRANSFER LIMITATION; PERFORMANCE; SUPPORT DEVICES; TRANSPORT PHENOMENON;

MASS TRANSFER;

ANIMAL CELL; ARTIFICIAL LIVER; BIOCOMPATIBILITY; CELL CULTURE; CONFERENCE PAPER; LIVER CELL; LIVER FAILURE; MEMBRANE TRANSPORT; NONHUMAN;

EID: 0029866772     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889601900105     Document Type: Conference Paper

References (70)

1. Matsushita M, Nosè Y. Artificial liver. Artif Organs 1986; 10 (5): 378-84.
2. Higgins GM, Andersen RM. Experimental pathology of the liver. Arch Pathol 1931; 31: 186-202.
3. Lin TY, Lee CS, Chen CC, Lian KY, Lin WSJ. Regeneration of human liver after hepatic lobectomy studies by repeated liver scanning and repeated needle biopsy. Ann Surg 1979; 190: 48-53.
4. Terblanche J, Starzl TE. Hepatic regeneration: implicated in fulminant hepatic failure. Int J Artif Organs 1979; 2: 49-52.
5. Fleig WE. Liver-specific growth factors. Scand J Gastroenterol 1988; 23: 31-6.
6. Nosè Y. Artificial liver for a bridge to liver transplantation. Artif Organs 1989; 13: 415-6.
7. Sorrentino F. Prime ricerche per la realizzazione di un fegato artificiale. Chir Patol Sper 1956; 4: 1401-14.
8. Sen PK, Bhalerao RA, Parulkar GP, Samsi AB, Shah BK, Kinare SG. Use of perfused cadaveric liver in the management of hepatic failure. Surgery 1966; 59: 774-81.
9. Abouna GM, Cook JS, Fisher LM, Still WJ, Costa G, Hume DM. Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions. Surgery 1972; 71: 537-47.
10. Lie TS. Treatment of acute hepatic failure by extracorporeal hemoperfusion over human and baboon liver. In: Brunner G, Schimdt FW, eds. Artificial liver support. Berlin: Springer-Verlag, 1981; 268-73.
11. Mito M. Hepatic assist: present and future. Artif Organs 1986; 10 (3): 214-8
12. Soyer T, Lempinen M, Walker JE, Supanwanid P, Eiseman B. Extracorporeal assist of anhepatic animals with liver slice perfusion. Am J Surg 1973; 126: 20-4.
13. Chang TMS. Hemoperfusion, exchange transfusion, cross circulation, liver perfusion, hormones and immobilized enzymes. In: Brunner G, Schmidt FW, eds. Artificial liver support. Berlin: Springer-Verlag, 1981; 126.
14. Nyberg SL, Shatford RA, Hu Ws, et al. Hepatocyte culture systems for artificial liver support: implications for critical care medicine (bioartificial liver support). Crit Care Med 1992; 20 (8): 1157-68.
15. Reid LM, Jefferson DM. Culturing hepatocytes and other differentiated cells. Hepatology 1984; 4: 548-59.
16. Spray DC, Fujita M, Saez JC, et al. Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures. J Cell Biol 1987; 105:: 541-51.
17. Warren M, Fry JR. Influence of medium composition on 7-alkoxycoumarin O-dealkylase activities of rat hepatocytes in primary maintenance culture. Xenobiotica 1988, 18: 973-81.
18. Sussman NL. Chong MG, Koussayer T, et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992; 16: 60-5.
19. Nyberg SL, Platt JL, Shirabe K, Payne WD, Hu W-S, Cerra FB. Immunoprotection of xenocytes in a hollow fiber bioartificial liver. ASAIO J 1992; M463-7.
20. Gerlach J, Encke J, Neuhaus P. Hepatocyte culture in bioreactors and the development of extracorporeal hybrid liver support systems. Transplantationsmedizin 1993; 6: 1-4.
21. Drioli E, Iorio G, Catapano G. Enzyme membrane reactors and membrane fermentors. In: Porter MC, ed. Handbook of industrial membrane technology. NY: Noyes Data, 1990; 401-81.
22. Gimson AES, Braude S, Mellon PJ, Clanese J, Williams R. Earlier charcoal hemoperfusion in fulminant hepatic failure. Lancet 1982; 2: 681-3.
23. Gerlach J, Kloppel K, Schauwecker HH, Tauber R, Muller CH, Bucherl ES. Use of hepatocytes in adesion and suspension cultures for liver support bioreactors. Int J Artif Organs 1989; 12: 788-92.
24. Jauregui HO, Naik S, Driscoll JL, Solomon BA, Galietti PM. Adult rat hepatocyte cultures as the cellular component of an artificial hybrid liver. In: Paul JP, ed. Biomaterials in artificial organs. Weinheim, Deerfield Beach FI: VCH, 1985; 130-40.
25. Gerlach J, Kloeppel K, Mueller C, et al. Hepatocyte aggregate culture technique for bioreactors in hybrid liver support systems. Int J Artif Organs 1993; 16 (12): 843-6.
26. Dunn JCY, Yarmush ML, Koebe HG, Tompkins RG. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J 1989; 3: 174-7.
27. Dunn JCY, Tompkins RG, Yarmush ML. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog 1991; 7: 237-45.
28. Bucher NL, Robinson GS, Farmer SR. Effects of extracellular matrix on hepatocyte growth and gene expression: implications for hepatic regeneration and the repair of liver injury. Semin Liver Dis 1990; 10: 11-9.
29. Bader A, Knop E, Boker K, Manns M, Reale E, Pichòmayr R. Three dimensional co-culture of hepatic sinusoidal cells. In: Knook DL, Wisse E, eds. Cells of the hepatic sinusoid. The Netherlands: AK Leiden, 1993; 14: 562-3.
30. Multer M. Basic principles of membrane technology. Dordrecht: Kluwer Academic Publishers, 1991.
31. Catapano G, Di Lorenzo MC, Della Volpe C, De Bartolo L, Falco F, Migliaresi C. Polymeric membranes for cell culture in a hybrid liver support device: effect of membrane morphology on hepatocyte viability and functions (submitted).
32. Gerlach J, Stoll P, Schnoy N, Buecherl ESB. Membranes as substrate for hepatocyte adhesion in liver support bioreactors. Int J Artif Organs 1990; 13 (7): 436-41.
33. Catapano G, Di Lorenzo MC, Della Volpe C, De Bartolo L, Falco F, Migliaresi C. Membrane polimeriche semipermeabili da adoperarsi come supporte per l'adesione di epatociti isolati in un fegato bioartificiale a membrane. Gnoseis (special Issue) 1994; 1 (1): 61.
34. Ward RA, Klein E, Harding GB, Murchison KE. Response of complement and neutrophils to hydrophilized synthetic membranes. Trans ASAIO 1988; 34 (3): 334-7.
35. Catapano G, Wodetzki A, Baurmeister U. Blood flow outside regularly spaced hollow fibers: the future concept of membrane devices? Int J Artif Organs 1992; 15 (4): 327-30.
36. Foy BD, Lee J, Morgan J, Toner M, Tompkins RG, Yarmush ML. Optimization of hepatocyte attachment to microcarriers: importance of oxygen. Biotechnol Bioeng 1993; 42: 579-88.
37. Catapano G, De Bartolo L, Lombardi CP, Drioli E. The effect of oxygen transport resistances on the viability and functions of isolated rat hepatocytes. Int J Artif Organs this issue.
38. Woelfle D, Jungermann K. Long-term effects of physiological oxygen concentrations on glycolysis and gluconeogenesis in hepatocyte cultures. Eur J Biochem 1985; 151: 299-303.
39. Kilburn DG, Webb FC. Biotechnol Bioeng 1968; 10: 801-14.
40. Balkin AK. J Cell Physiol 1976; 89: 235-50.
41. Nyberg SL, Shatford RA, Peshwa MV, White JG, Cerra FB, Hu WS. Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liver. Biotechnol Bioeng 1993; 41: 194-203.
42. Glacken MW, Fleischaker RJ, Sinskey AJ. Reduction of waste product excretion via nutrient control: possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells. Biotechnol Bioeng 1986; 28: 1376-89.
43. Piret JM, Devens DA, Cooney CL. Nutrient and metabolite gradients in mammalian cell hollow fiber bioreactors. Canad J Chem Eng 1991; 69: 421-8.
44. Catapano G, De Bartolo L. The effect of catabolites concentration on the viability and functions of isolated rat hepatocytes (submitted).
45. March DC, Hjelmhaug PK, Vreugdenhil PK, et al. Hypothermie preservation of hepatocytes. III. Effects of resuspension media on viability after up to 7 days of storage. Hepatology 1991; 13 (3): 500-8.
46. Berry MN, Edwards AM, Barritt GJ, et al. Isolated hepatocytes preparation, properties and application. In: Burdon RH, van Knippenberg PH, eds. Laboratory techniques in biochemistry and molecular biology. Amsterdam-New York-Oxford: Elsevier, 1991; 21: 265-353.
47. Middleman S. Cardiovascular transport phenomena. New York: Wiley-lnterscience, 1972.
48. Whitmore RL. Rheology of the circulation. Oxford: Pergamon Press, 1968.
49. Wickramasinghe SRE, Semmens MJ, Cussler EL. Mass transfer in various hollow fiber geometries. J Membrane Sci 1992; 69: 235-50.
50. Catapano G, Bergins M, Papenfuss HD, Rintelen T, Baurmeister U. Mass and momentum transport in cross-wound hollow fiber devices with extra-luminal flow (ELF). International Congress on Membrane (ICOM) '90. Chicago, IL (USA): August 20-24, 1990.
51. Beck RE, Schultz JE. Biochem Biophys Acta 1972; 255: 273-303.
52. Klein E, Holland FF, Eberle K. Comparison of experimental and calculated permeability and rejection coefficients for hemodialysis membranes. J Membrane Sci 1979; 5: 173-88.
53. Wendt RP, Klein E, Bresler EH, Holland FF, Serino RM, Villa H. Sieving properties of hemodialysis membranes. J Membrane Sci 1979; 5: 23-49.
54. Chresand TJ, Gillies RJ, Dale BE. Optimum fiber spacing in a hollow fiber bioreactor. Biotechnol Bioeng 1988; 32: 983-92.
55. Pillarella MR, Zidney A. Effect of beta cell distribution on the performance of a bioartificial pancreas. Trans ASAIO 1990; 36: M715-9.
56. Todd DG, Moscioni AD, Rozga J, Demetriou AA. Mass transfer in a hollow fiber device used as a bioartificial liver. ASAIO J 1993; 886-92.
57. Catapano G, Iorio G, Drioli E, et al. Theoretical and experimental analysis of a hybrid bioartificial membrane pancreas: a distributed parameter model taking into account Starling fluxes. J Membrane Sci 1990; 52: 351-78.
58. Satterfield CN. Mass transfer in heterogeneous catalysis. Florida: RE Krieger, 1980.
59. Rony PR. Biotechnol Bioeng 1971; 13: 431-47.
60. Sun AM, Parisius W, Mealy GM, Vacek I, Macmorine HG. The use in diabetic rats and monkeys, of artificial capillary units containing cultured islets of Langerhans (artificial endocrine pancreas). Diabetes 1977; 26 (12): 1136.
61. Knazek RA, Gullino PM, Kohler PO, Dedrick RL. Cell culture on artificial capillaries: an approach to issue growth in vitro. Science 1972; 178: 65-7.
62. Matsura KN, Robles Guevara G, Huston H, et al. Hybrid bioartificial liver in hepatic failure: preliminary clinical report. Surgery 1987; 101 (1): 99-103.
63. Arnaout WS, Moscioni AD, Barbour RL, Demetriou AA. Development of bioartificial liver: bilirubin conjugation in Gunn rats. J Surg Res 1990; 48: 379-82.
64. Demetriou AA, Whiting JF, Stanley M, et al. New method of hepatocyte transplantation and extracorporeal liver support. Ann Surg 1986; 204: (3): 259-70.
65. Wolf CFW, Minick CR, McCoy CH. Morphologic examination of a prototype liver assist device composed of cultured cells and artificial capillaries. Int J Actif Organs 1978; 1 (1): 45-51.
66. Sussman NL, Kelly JH. Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs 1993; 17 (1): 27-30.
67. Gerlach J, Schnoy N, Smith MD, Neuhaus P. Hepatocyte culture between woven capillary networks: a microscopy study. Artif Organs 1994; 18 (3): 226-30.
68. Adema E, Sinskey AJ. An analysis of intra- versus extracapillary growth in a hollow fiber reactor. Biotechnol Progress 1987; 3 (2): 74-9.
69. Gaylor J. Hepatocyte oxygenation in bioreactors. XX Annual ESAO '94 Meeting, 20-22 October 1994, Barcellona, Spain.
70. Andrade JD, Hlady V. Plasma protein adsorption: the big twelve. Ann NY Acad Sci 1987; 158-72.